[go: up one dir, main page]

AR061985A1 - ORAL PHARMACEUTICAL COMPOSITIONS, PARTICULARLY SUITABLE TO RELIEF COLD, TOS, FLU, FEVER, JAQUECA, PAIN, BODY PAIN, MIGRAINE OR ALLERGIC SYMPTOMS - Google Patents

ORAL PHARMACEUTICAL COMPOSITIONS, PARTICULARLY SUITABLE TO RELIEF COLD, TOS, FLU, FEVER, JAQUECA, PAIN, BODY PAIN, MIGRAINE OR ALLERGIC SYMPTOMS

Info

Publication number
AR061985A1
AR061985A1 ARP070103111A ARP070103111A AR061985A1 AR 061985 A1 AR061985 A1 AR 061985A1 AR P070103111 A ARP070103111 A AR P070103111A AR P070103111 A ARP070103111 A AR P070103111A AR 061985 A1 AR061985 A1 AR 061985A1
Authority
AR
Argentina
Prior art keywords
pain
oral pharmaceutical
jaqueca
tos
flu
Prior art date
Application number
ARP070103111A
Other languages
Spanish (es)
Inventor
Bubnis William
Shield Stephanie
P Hoskovec Gayle
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38814551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR061985(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR061985A1 publication Critical patent/AR061985A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composición farmacéutica líquida, oral, que comprende fenilefrina y polietilenglicol sustancialmente libre de aldehídos. La composición tiene fenilefrina compatible establemente con la requerida estabilidad para preparaciones comerciales. Opcionalmente, la composición puede comprender uno o más agentes activos adicionales como por ejemplo, dextrometorfan, guaifenesina, acetaminofen, maleato de clorfeniramina, etc..A liquid, oral pharmaceutical composition comprising phenylephrine and polyethylene glycol substantially free of aldehydes. The composition has phenylephrine stably compatible with the required stability for commercial preparations. Optionally, the composition may comprise one or more additional active agents such as dextromethorphan, guaifenesin, acetaminophen, chlorpheniramine maleate, etc.

ARP070103111A 2006-07-14 2007-07-13 ORAL PHARMACEUTICAL COMPOSITIONS, PARTICULARLY SUITABLE TO RELIEF COLD, TOS, FLU, FEVER, JAQUECA, PAIN, BODY PAIN, MIGRAINE OR ALLERGIC SYMPTOMS AR061985A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/487,120 US20080014274A1 (en) 2006-07-14 2006-07-14 Enhanced stability phenylephrine liquid compositions

Publications (1)

Publication Number Publication Date
AR061985A1 true AR061985A1 (en) 2008-08-10

Family

ID=38814551

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103111A AR061985A1 (en) 2006-07-14 2007-07-13 ORAL PHARMACEUTICAL COMPOSITIONS, PARTICULARLY SUITABLE TO RELIEF COLD, TOS, FLU, FEVER, JAQUECA, PAIN, BODY PAIN, MIGRAINE OR ALLERGIC SYMPTOMS

Country Status (26)

Country Link
US (1) US20080014274A1 (en)
EP (2) EP2040672B1 (en)
JP (1) JP2009543777A (en)
KR (2) KR20090040334A (en)
CN (2) CN104546671A (en)
AR (1) AR061985A1 (en)
AU (1) AU2007272961B2 (en)
BR (1) BRPI0714399B8 (en)
CA (1) CA2657611A1 (en)
CO (1) CO6180496A2 (en)
EC (1) ECSP099072A (en)
ES (2) ES2537761T3 (en)
HK (1) HK1205933A1 (en)
HU (2) HUE025694T2 (en)
IL (1) IL196447A (en)
MX (1) MX2009000530A (en)
NZ (1) NZ574148A (en)
PE (1) PE20081003A1 (en)
PL (2) PL2351554T3 (en)
PT (2) PT2351554E (en)
RU (1) RU2468787C2 (en)
SG (2) SG173354A1 (en)
TW (1) TW200812640A (en)
UY (1) UY30484A1 (en)
WO (1) WO2008008364A2 (en)
ZA (1) ZA200900315B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
TWI411451B (en) * 2006-06-01 2013-10-11 Msd Consumer Care Inc Phenylephrine pharmaceutical formulations and compositions for colonic absorption
CA2653955C (en) * 2006-06-01 2015-10-27 Schering Corporation Pharmaceutical compositions for sustained release of phenylephrine
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
US20070281019A1 (en) * 2006-06-01 2007-12-06 Ulloa Sergio R Phenylephrine pulsed release formulations and pharmaceutical compositions
BRPI0812784A2 (en) * 2007-06-01 2014-12-02 Schering Plough Healthcare Pharmaceutical composition comprising a substrate and a coating containing an active ingredient and polyvinyl alcohol
PE20091084A1 (en) * 2007-12-07 2009-07-23 Schering Plough Healthcare PHARMACEUTICAL FORMULATIONS OF PHENYLPHRINE AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2802362C (en) * 2010-06-11 2017-11-21 Gm Pharmaceuticals, Inc. Pharmaceutical compositions for alleviating upper respiratory and oral-pharyngeal congestion
KR20190085561A (en) 2010-10-21 2019-07-18 알티유 파머수티컬즈, 엘엘시 Ready to use ketorolac formulations
FR2987268B1 (en) * 2012-02-28 2014-07-11 Ammtek LIQUID FORMULATIONS OF HYPOGLYCEMIC SULFAMIDES
CN105007891B (en) * 2013-02-28 2018-01-16 辉瑞公司 Enhanced stability of new liquid compositions
JP6539274B2 (en) 2013-08-12 2019-07-03 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド Extruded immediate release abuse deterrent pills
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
US20160106737A1 (en) 2014-10-20 2016-04-21 Pharmaceutical Manufacturing Research Services, Inc. Extended Release Abuse Deterrent Liquid Fill Dosage Form
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
JP5918895B1 (en) * 2015-05-21 2016-05-18 富士カプセル株式会社 Nalfurafine hydrochloride-containing capsule formulation
AU2016270504A1 (en) * 2015-05-29 2017-12-14 Codadose Incorporated Liquid formulations of celecoxib for oral administration
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
WO2018045170A1 (en) * 2016-09-01 2018-03-08 The Procter & Gamble Company Medication with improved taste and sensory experience
PL3515413T3 (en) 2016-09-26 2023-11-13 The Procter & Gamble Company DOSAGE FORM FOR PROLONGED RELIEF
CN110115708A (en) * 2018-02-07 2019-08-13 保瑞药业股份有限公司 Acetaminophen and C16H25NO2 are total to molten compound analgesic oral liquor
CR20200552A (en) 2018-05-16 2021-05-13 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
CN108434097A (en) * 2018-06-22 2018-08-24 南京济群医药科技股份有限公司 A kind of hydrochloric triprolidine oral solution of stabilization and preparation method thereof
CN109010341A (en) * 2018-10-29 2018-12-18 南京济群医药科技股份有限公司 A kind of compound oral solution and preparation method thereof containing dextromethorphan hydrobromide
MX2021012356A (en) 2019-04-11 2021-11-04 Scherer Technologies Llc R P Formulation for oral delivery of proteins, peptides and small molecules with poor permeability.
CA3164495C (en) 2019-12-23 2024-11-05 Nutra Essential Otc, S.L. Liquid composition comprising ibuprofen and phenylephrine
WO2021150747A1 (en) * 2020-01-22 2021-07-29 Nevakar Inc. Phenylephrine hydrochloride compositions and containers
CN111773203B (en) * 2020-05-15 2024-11-26 北京博智绿洲医药科技有限公司 A preparation process of a composition containing phenylephrine hydrochloride
CN114533664B (en) * 2022-01-29 2023-03-31 江苏广承药业有限公司 Compound oral liquid preparation of dextromethorphan hydrobromide and guaiacol glyceryl ether

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
US5616621A (en) 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
DE69815003T2 (en) * 1997-09-10 2004-04-01 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6287597B1 (en) 1999-03-12 2001-09-11 Carter-Wallace, Inc. Antihistaminic/decongestant compositions
JP3450805B2 (en) * 2000-08-08 2003-09-29 わかもと製薬株式会社 Aqueous pharmaceutical composition
BR0211794A (en) 2001-07-31 2004-11-03 Wyeth Corp Pharmaceutical composition and method for masking the taste of at least one unpleasant tasting pharmaceutically active compound
US6462094B1 (en) * 2001-08-22 2002-10-08 Medpointe Healthcare Inc. Decongestant/expectorant compositions
US20030060422A1 (en) * 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US6509492B1 (en) * 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US20040132827A1 (en) 2001-10-26 2004-07-08 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
EP1559433A4 (en) 2002-10-22 2009-11-04 Dainippon Sumitomo Pharma Co STABILIZED COMPOSITION
US6979689B2 (en) 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
JP2004300138A (en) * 2003-03-18 2004-10-28 Takeda Chem Ind Ltd Stabilized oral solid dosage form
US20050152967A1 (en) 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
DE10358213A1 (en) 2003-12-12 2005-07-28 Clariant Gmbh Polyethylene glycol and its preparation
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006022996A2 (en) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20060148837A1 (en) 2005-01-04 2006-07-06 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070098785A1 (en) * 2005-11-02 2007-05-03 Tim Clarot Medicant delivery system and device
US20070160689A1 (en) * 2006-01-12 2007-07-12 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070254027A1 (en) 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness

Also Published As

Publication number Publication date
SG173354A1 (en) 2011-08-29
ES2550036T3 (en) 2015-11-04
PE20081003A1 (en) 2008-07-13
CO6180496A2 (en) 2010-07-19
HK1128886A1 (en) 2009-11-13
BRPI0714399A2 (en) 2013-03-12
UY30484A1 (en) 2008-02-29
IL196447A0 (en) 2009-09-22
TW200812640A (en) 2008-03-16
RU2468787C2 (en) 2012-12-10
JP2009543777A (en) 2009-12-10
MX2009000530A (en) 2009-01-27
KR20140088234A (en) 2014-07-09
IL196447A (en) 2015-06-30
ECSP099072A (en) 2009-02-27
CA2657611A1 (en) 2008-01-17
ES2537761T3 (en) 2015-06-11
US20080014274A1 (en) 2008-01-17
BRPI0714399B8 (en) 2021-05-25
PT2351554E (en) 2015-11-02
PL2351554T3 (en) 2016-01-29
PL2040672T3 (en) 2015-07-31
EP2351554A1 (en) 2011-08-03
EP2351554B1 (en) 2015-09-09
RU2009101295A (en) 2010-08-27
BRPI0714399B1 (en) 2020-11-17
EP2040672A2 (en) 2009-04-01
KR20090040334A (en) 2009-04-23
HUE025790T2 (en) 2016-05-30
ZA200900315B (en) 2009-12-30
EP2040672B1 (en) 2015-04-01
PT2040672E (en) 2015-07-02
CN104546671A (en) 2015-04-29
SG10201408522UA (en) 2015-02-27
AU2007272961B2 (en) 2011-07-28
HK1205933A1 (en) 2015-12-31
WO2008008364A2 (en) 2008-01-17
AU2007272961A1 (en) 2008-01-17
NZ574148A (en) 2012-07-27
WO2008008364A3 (en) 2008-05-22
HUE025694T2 (en) 2016-04-28
CN101500539A (en) 2009-08-05

Similar Documents

Publication Publication Date Title
AR061985A1 (en) ORAL PHARMACEUTICAL COMPOSITIONS, PARTICULARLY SUITABLE TO RELIEF COLD, TOS, FLU, FEVER, JAQUECA, PAIN, BODY PAIN, MIGRAINE OR ALLERGIC SYMPTOMS
PE20121820A1 (en) (2S, 3R) -N- (2 - ((3-PYRIDINYL) METHYL) -1-AZABICYCLE [2.2.2] OCT-3-IL) BENZOFURAN-2-CARBOXAMIDE, NOVEL SALTS FORMS OF IT, AND METHODS OF USE OF IT
AR048878A1 (en) TOPIC COMPOSITIONS OF METADONA AND METHODS FOR USE
CL2020000468A1 (en) Use of a stable formulation comprising a replacement enzyme for the lysosomal enzyme (divisional application 201801220)
CL2009001936A1 (en) Pyridazine derived compounds, 11beta-hsd1 inhibitors; pharmaceutical composition; preparation procedure; and use in the treatment of diabetes, obesity, dyslipidemia, eating disorders and hypertension (divisional application 1720-2006).
CL2017001847A1 (en) A solid pharmaceutical dosage formulation
AR033023A1 (en) TOPICAL COMPOSITION
BRPI0414581C1 (en) compound, pharmaceutical composition comprising said compound and use of said compound
AR093115A1 (en) INJECTABLE, STABLE AND CONSERVANT-FREE MIDRIATIC AND ANTI-INFLAMMATORY SOLUTIONS
CL2009000882A1 (en) A compound n- (4-chloro-3- (pyridin-2-yl) phenyl) -4- (2-hydroxy-2-methylpropylsulfonyl) -2-methylbenzamide, inhibitor of the hedgehog signaling pathway; pharmaceutical composition comprising said compound; and its use to treat cancer.
PE20110010A1 (en) LIQUID PHENYLEPHRINE FORMULATIONS
MX2009004203A (en) Acetaminophen / ibuprofen combinations.
ECSP077261A (en) HER2 ANTIBODY COMPOSITION
EP2019857A4 (en) SYNERGISTIC ADJUVANT COMBINATION OF CD40 AGONIST ANTIBODY / INTERFERON TYPE 1, CONJUGATES CONTAINING SUCH A COMBINATION AND USE AS A THERAPEUTIC AGENT FOR IMPROVING CELLULAR IMMUNITY
CL2007003686A1 (en) COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
PE20140960A1 (en) FORMULATIONS INVOLVING A DPP4 INHIBITOR
ECSP088903A (en) PHARMACEUTICAL COMPOSITIONS OF ANTI-CD40 ANTIGONIST ANTIBODY
ATE509636T1 (en) COMBINATION OF A CHOLINESTERASE INHIBITOR AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY
CL2008003537A1 (en) 2-aminopyrimidine derived compounds, h4 receptor antagonists; preparation procedure; pharmaceutical composition comprising said compound; and use of the compound in the treatment of an allergic, immunological or inflammatory disease or pain.
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
NI201000189A (en) SOLID MEDICINE FORMULATION WITH DELAYED RELEASE.
EA201170512A1 (en) COMPOSITION FOR ORAL ADMINISTRATION
CY1109537T1 (en) Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION
UA87841C2 (en) Topical composition containing ambroxol
CL2008001810A1 (en) Compounds derived from spiroindolines, chemokine receptor modulators; pharmaceutical composition comprising said compounds; and its use to treat atherosclerosis, inflammatory pain, influenza, metabolic syndrome, among other diseases.

Legal Events

Date Code Title Description
FB Suspension of granting procedure